Market Overview:
The global polypectomy forcep market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of colorectal cancer and other gastrointestinal disorders, rising demand for minimally invasive surgeries, and technological advancements in polypectomy forceps. Based on type, the global polypectomy forcep market can be segmented into hot and cold polypectomy forceps. The hot polypectomy forceps segment is expected to account for a larger share of the market than the cold polypectomy forceps segment during the forecast period. This can be attributed to their ability to cut through tissue quickly and easily without causing any damage. Based on application, the global Polypectomy Forcep Market can be divided into clinic and hospital applications. The clinic application segment is expected to account for a larger share of the market than hospital applications duringthe forecast period owingtoits lower costand easeofuse .Based on region,theglobalpolyectom yforcepmarketcanbeb dividedintoNorth America ,Latin America ,Europe Asia PacificandMiddle East&Africa .
Product Definition:
A polypectomy forcep is a tool used to remove polyps from the body. Polyps are small growths that can form on the lining of organs such as the colon or uterus. They can often be removed without surgery, using a special tool called a polypectomy forcep.
Hot:
The global hot is used for the treatment of polypectomy and it's growth factor in the market is Polypectomy (PP) or more commonly known as a "sphincteroplasty". Hot is a surgical instrument that helps surgeons to open up blocked ducts in various parts of the body. It also aids in removing excess fluid from certain body parts like lungs, kidney, & liver.
Cold:
The cold and it’s usage in polypectomy forceps market is expected to witness significant growth over the forecast period. The rising prevalence of cancer across the globe, increasing geriatric population base, technological advancements in medical devices industry are some high impact rendering drivers for this market.
Application Insights:
Based on the application, the market is segmented into a clinic, hospital and others. The clinic segment dominated the overall market in terms of revenue in 2017. Polypectomy forceps are most commonly used for treating acute as well as chronic conditions such as esophageal stricture, gastroesophageal reflux disease (GERD), adenocarcinoma of the stomach and pancreatic cancer among others.
The hospital segment is expected to exhibit lucrative growth over the forecast period owing to rising prevalence of diseases requiring polypectomy forceps treatment such as esophageal cancer, gastric cancer and pancreatic cancer among others across hospitals globally. In addition, increasing number of research studies supporting its usage for various indications including acute pancreatitis and duodenal ulcer healing also supports its demand at a global level.
Regional Analysis:
North America dominated the global polypectomy forceps market in 2017. This can be attributed to factors such as high incidence of breast cancer, presence of well-established healthcare facilities and availability of highly skilled physicians. Moreover, rising awareness regarding early detection and treatment is anticipated to fuel the demand for diagnostic tools in this region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing prevalence of breast cancer coupled with growing medical tourism industry in countries such as India, China and Japan. In addition, government initiatives aimed at improving public health system are likely to contribute towards increased demand for these devices during the forecast period from 2018-2030 in Asia Pacific region.
Europe also held a significant share due its developed economy along with presence of major players operating across various sectors including medical & dental instruments manufacturing space which has led it being a key regional market player throughout history thus far (aside from other developments).
Growth Factors:
- Increasing incidence of colorectal cancer: The incidence of colorectal cancer is increasing at a rapid pace across the globe. This is primarily attributed to the changing lifestyle and dietary habits. Colorectal cancer can be effectively treated with polypectomy forceps, which is driving the demand for these instruments.
- Growing awareness about early detection and prevention of colorectal cancer: There is a growing awareness among people about the importance of early detection and prevention of colorectal cancer. This is helping to boost the demand for polypectomy forceps globally.
- Technological advancements in polypectomy forceps: The technology used in manufacturing polypectomy forceps is constantly evolving, which is resulting in better performance and efficiency of these instruments. This is propelling their adoption across hospitals and clinics worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polypectomy Forcep Market Research Report
By Type
Hot, Cold
By Application
Clinic, Hospital
By Companies
Medline, B. Braun, CareFusion, Lawton, Teleflex Medical, Delacroix Chevalier, MedGyn Products, Inami, Ted Pella, J & J Instruments, American Diagnostic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Polypectomy Forcep Market Report Segments:
The global Polypectomy Forcep market is segmented on the basis of:
Types
Hot, Cold
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medline
- B. Braun
- CareFusion
- Lawton
- Teleflex Medical
- Delacroix Chevalier
- MedGyn Products
- Inami
- Ted Pella
- J & J Instruments
- American Diagnostic
Highlights of The Polypectomy Forcep Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hot
- Cold
- By Application:
- Clinic
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polypectomy Forcep Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A polypectomy forceps is a medical instrument used to remove tissue from an area of the body. It consists of a pair of metal jaws that are hinged at the base and can be opened wide to grab hold of tissue. The forceps are then closed around the tissue, cutting it off from the rest of the body.
Some of the major players in the polypectomy forcep market are Medline, B. Braun, CareFusion, Lawton, Teleflex Medical, Delacroix Chevalier, MedGyn Products, Inami, Ted Pella, J & J Instruments, American Diagnostic.
The polypectomy forcep market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Polypectomy Forcep Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Polypectomy Forcep Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Polypectomy Forcep Market - Supply Chain
4.5. Global Polypectomy Forcep Market Forecast
4.5.1. Polypectomy Forcep Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Polypectomy Forcep Market Size (000 Units) and Y-o-Y Growth
4.5.3. Polypectomy Forcep Market Absolute $ Opportunity
5. Global Polypectomy Forcep Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Polypectomy Forcep Market Size and Volume Forecast by Type
5.3.1. Hot
5.3.2. Cold
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Polypectomy Forcep Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Polypectomy Forcep Market Size and Volume Forecast by Application
6.3.1. Clinic
6.3.2. Hospital
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Polypectomy Forcep Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Polypectomy Forcep Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Polypectomy Forcep Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Polypectomy Forcep Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Polypectomy Forcep Demand Share Forecast, 2019-2026
9. North America Polypectomy Forcep Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Polypectomy Forcep Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Polypectomy Forcep Market Size and Volume Forecast by Application
9.4.1. Clinic
9.4.2. Hospital
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Polypectomy Forcep Market Size and Volume Forecast by Type
9.7.1. Hot
9.7.2. Cold
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Polypectomy Forcep Demand Share Forecast, 2019-2026
10. Latin America Polypectomy Forcep Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Polypectomy Forcep Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Polypectomy Forcep Market Size and Volume Forecast by Application
10.4.1. Clinic
10.4.2. Hospital
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Polypectomy Forcep Market Size and Volume Forecast by Type
10.7.1. Hot
10.7.2. Cold
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Polypectomy Forcep Demand Share Forecast, 2019-2026
11. Europe Polypectomy Forcep Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Polypectomy Forcep Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Polypectomy Forcep Market Size and Volume Forecast by Application
11.4.1. Clinic
11.4.2. Hospital
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Polypectomy Forcep Market Size and Volume Forecast by Type
11.7.1. Hot
11.7.2. Cold
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country 11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Polypectomy Forcep Demand Share, 2019-2026
12. Asia Pacific Polypectomy Forcep Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Polypectomy Forcep Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Polypectomy Forcep Market Size and Volume Forecast by Application
12.4.1. Clinic
12.4.2. Hospital
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Polypectomy Forcep Market Size and Volume Forecast by Type
12.7.1. Hot
12.7.2. Cold
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Polypectomy Forcep Demand Share, 2019-2026
13. Middle East & Africa Polypectomy Forcep Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Polypectomy Forcep Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Polypectomy Forcep Market Size and Volume Forecast by Application
13.4.1. Clinic
13.4.2. Hospital
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Polypectomy Forcep Market Size and Volume Forecast by Type
13.7.1. Hot
13.7.2. Cold
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Polypectomy Forcep Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Polypectomy Forcep Market: Market Share Analysis
14.2. Polypectomy Forcep Distributors and Customers
14.3. Polypectomy Forcep Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. B. Braun
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CareFusion
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lawton
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teleflex Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Delacroix Chevalier
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MedGyn Products
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Inami
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ted Pella
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. J & J Instruments
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. American Diagnostic
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
